NVST Stock Chart & Stats
$370.00
$0.00(0.00%)
At close: 4:00 PM EDT
$370.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$365.00 - $400.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$70.94B
Enterprise Value$5.00B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)39.8
Beta>-0.01
Next Earnings
Nov 04, 2026EPS Estimate
6.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.59
Shares Outstanding160,617,700
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$552.04Price Target Upside49.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)28.57
Revenue Forecast (FY)$53.76B
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Market ReachRising sales across a broad dental portfolio indicate improving demand and market reach. Growth in both equipment and consumables supports a balanced model, while continued product adoption can reinforce recurring purchasing and create a durable base for expansion.
Margin ExpansionImproving gross and EBITDA margins show that recent growth is translating into stronger operating leverage rather than only higher revenue. If sustained, the gains can support reinvestment in innovation, strengthen earnings resilience, and improve the company’s ability to absorb cost pressures.
Cash Generation And Balance SheetStrong free cash flow combined with low net leverage gives Envista capacity to fund research, commercial initiatives, acquisitions, and shareholder returns. This financial flexibility can help the company manage operating volatility without relying heavily on additional borrowing.
Bears Say
Thin And Volatile ProfitabilityDespite improving revenue and operating performance, the low net margin leaves limited room for execution mistakes, cost inflation, or weaker demand. Prior losses also show that earnings conversion has not yet demonstrated the consistency expected from a durable improvement.
China VBP Pricing PressurePotential China VBP reductions represent a structural pricing challenge in important implant and orthodontic categories. Lower realized prices could offset volume or share gains, pressure segment margins, and make sustained growth more dependent on geographic and product diversification.
Cyclical Category ExposureExposure to elective implants and orthodontics makes part of Envista’s demand sensitive to practice investment and regional economic conditions. Uneven performance across markets can reduce growth consistency and complicate planning for capacity, inventory, and commercial spending.
NVST FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was $365.00 and its highest was $400.00 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is $70.94B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is Nov 04, 2026 which is in 3 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on Aug 05, 2026. The company reported $7.703 earnings per share for the quarter, beating the consensus estimate of $6.294 by $1.409.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Undervalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 6.69.
How many shares outstanding does Envista Holdings Corp have?
Envista Holdings Corp has 160,617,700 shares outstanding.
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of $7.703 in its last earnings report, beating expectations of $6.294. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in MX:NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$552.04 (49.20% Upside)
$552.04 (49.20% Upside)
Blogger Sentiment
Bullish
MX:NVST Sentiment 80%
Sector Average 64%
Sector Average 64%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.73%
12-Months-Change
Fundamentals
Return on Equity
3.08%
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Company Deck
NVST Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reported a strong quarter with broad-based revenue growth, meaningful margin expansion, large EPS and free-cash-flow improvement, a strengthened balance sheet and raised full-year guidance. Operational highlights included robust E&C performance, double-digit Spark growth, successful new product launches, and continued share gains. Headwinds and risks were manageable and largely named and quantified: China VBP-driven price pressure and timing uncertainty, a Q4 billing-day calendar headwind, tariff-related costs, and the end of a small deferral tailwind. Overall, management framed the issues as addressable while emphasizing continued momentum, investment in R&D and commercial initiatives, and confidence in the raised guidance.View all MX:NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables

NVST Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$552.04
▲(49.20% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month












